Advances in islet encapsulation technologies (Q39051114)

8 September 2017

Advances in islet encapsulation technologies (English)

1 reference

8 September 2017

Tejal Desai

1

1 reference

8 September 2017

Lonnie D Shea

series ordinal

2

1 reference

8 September 2017

23 December 2016

1 reference

Nature Reviews Drug Discovery

8 September 2017

1 reference

8 September 2017

16

1 reference

8 September 2017

5

1 reference

8 September 2017

338-350

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd.2016.232

8 September 2017

0 references

cites work

Five-year follow-up after clinical islet transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Improvement in outcomes of clinical islet transplantation: 1999-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

International trial of the Edmonton protocol for islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Treatment options for diabetes: potential role of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Closing in on Mass Production of Mature Human Beta Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Islet transplantation and encapsulation: an update on recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Nanoporous microsystems for islet cell replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Exercise induces hypoglycemia in rats with islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Polycaprolactone Thin-Film Micro- and Nanoporous Cell-Encapsulation Devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

SEMIPERMEABLE MICROCAPSULES

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Microencapsulated islets as bioartificial endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

An encapsulation system for the immunoisolation of pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Islet transplantation in rodents. Do encapsulated islets really work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Survival of microencapsulated adult pig islets in mice in spite of an antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Return to normal of blood-glucose, plasma-insulin, and weight gain in New Zealand obese mice after implantation of islets of Langerhans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Studies of hereditary-obese mice (obob) after implantation of pancreatic islets in Millipore filter capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Local inflammatory response around diffusion chambers containing xenografts. Nonspecific destruction of tissues and decreased local vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Long-term reversal of diabetes by the injection of immunoprotected islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Islet transplantation as a treatment for diabetes - a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Functional differences between aggregated and dispersed insulin-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Compliant 3D microenvironment improves β-cell cluster insulin expression through mechanosensing and β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Silica sol-gel encapsulation of pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Tunable Microfibers Suppress Fibrotic Encapsulation via Inhibition of TGFβ Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Device design and materials optimization of conformal coating for islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Oxygen supply to encapsulated therapeutic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The effects of cell density and device arrangement on the behavior of macroencapsulated beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Characterization of a nanogland for the autotransplantation of human pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The hypoxia response pathway and β-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Islet vasculature as a regulator of endocrine pancreas function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Cellular hypoxia of pancreatic beta-cells due to high levels of oxygen consumption for insulin secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

A theoretical study of oxygen transfer including cell necrosis for the design of a bioartificial pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Intraportal islet oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

A prevascularized subcutaneous device-less site for islet and cellular transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Improvement of subcutaneous bioartificial pancreas vascularization and function by coencapsulation of pig islets and mesenchymal stem cells in primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Oxygen producing biomaterials for tissue regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Oxygen generating scaffolds for enhancing engineered tissue survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Photosynthetic oxygen generator for bioartificial pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Transplantation of human islets without immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Attenuation of lipopolysaccharide-induced acute lung injury by treatment with IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Engineered VEGF-releasing PEG-MAL hydrogel for pancreatic islet vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Spatially localized recruitment of anti-inflammatory monocytes by SDF-1α-releasing hydrogels enhances microvascular network remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Manipulating the intersection of angiogenesis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The impact of infection and tissue damage in solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Following TRAIL's path in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Controlled release strategies for modulating immune responses to promote tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Safety and viability of microencapsulated human islets transplanted into diabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Expression of heme oxygenase-1 in neural stem/progenitor cells as a potential mechanism to evade host immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Neural stem/progenitor cells induce conversion of encephalitogenic T cells into CD4+-CD25+- FOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Neural stem/progenitor cells modulate immune responses by suppressing T lymphocytes with nitric oxide and prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Transforming growth factor-beta 1 delivery from microporous scaffolds decreases inflammation post-implant and enhances function of transplanted islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Proangiogenic scaffolds as functional templates for cardiac tissue engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Analysis on migration and activation of live macrophages on transparent flat and nanostructured titanium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Effect of electrospun fiber diameter and alignment on macrophage activation and secretion of proinflammatory cytokines and chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Early growth response-2 signaling mediates immunomodulatory effects of human multipotential stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Mechanisms of mesenchymal stromal cell immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Co-transplantation of islets with mesenchymal stem cells in microcapsules demonstrates graft outcome can be improved in an isolated-graft model of islet transplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Mechanisms Underlying CD4+ Treg Immune Regulation in the Adult: From Experiments to Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Immune Tolerance for Autoimmune Disease and Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Regulatory T-cell therapy for transplantation: how many cells do we need?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Islet xenotransplantation from genetically engineered pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Pig-to-monkey islet xenotransplantation using multi-transgenic pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Control of IBMIR in neonatal porcine islet xenotransplantation in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

A novel monoclonal antibody to CD40 prolongs islet allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Advancing islet transplantation: from engraftment to the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Pig-to-nonhuman primate islet xenotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Long-term metabolic control of autoimmune diabetes in spontaneously diabetic nonobese diabetic mice by nonvascularized microencapsulated adult porcine islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 2b: genetically modified source pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The role of genetically engineered pigs in xenotransplantation research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Optimization and Scale-up Isolation and Culture of Neonatal Porcine Islets: Potential for Clinical Application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Generation of functional human pancreatic β cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Efficient differentiation of human embryonic stem cells to definitive endoderm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Reprogrammed Stomach Tissue as a Renewable Source of Functional β Cells for Blood Glucose Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Enhanced oxygen supply improves islet viability in a new bioartificial pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The histological structure of some human lung cancers and the possible implications for radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Macroencapsulation protects against sensitization after allogeneic islet transplantation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: studies in a rodent model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The TheraCyte™ Device Protects against Islet Allograft Rejection in Immunized Hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Bioengineering the Endocrine Pancreas: Intraomental Islet Transplantation Within a Biologic Resorbable Scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Pituitary cell differentiation from stem cells and other cells: toward restorative therapy for hypopituitarism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Bioengineering the ovarian follicle microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Aging and age-related diseases--from endocrine therapy to target therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Spheramine for treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Creating immune privilege: active local suppression that benefits friends, but protects foes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Minor histocompatibility antigens: past, present, and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Treatment of diabetes with encapsulated islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Production of purified alginates suitable for use in immunoisolated transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Neovascularization of synthetic membranes directed by membrane microarchitecture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Preclinical development of the Islet Sheet.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Differential effects of transforming growth factor-beta 1 on interleukin-1-induced cellular inflammation and vascular permeability in the rabbit retina

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Coating human pancreatic islets with CD4(+)CD25(high)CD127(-) regulatory T cells as a novel approach for the local immunoprotection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

The effect of endothelial cells on hESC-derived pancreatic progenitors in a 3D environment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Stratifying Patients Based on Epitope Mismatching: Ready for Primetime?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.232

Efficacy of mesh reinforced polyvinylalcohol tube as a novel device for bioartificial pancreas: a functional study of rat islets in vivo

31 March 2020

1 reference

12 December 2020

Induction of cytokine production from human monocytes stimulated with alginate

1 reference

12 December 2020

Effect of oxygen supply on the size of implantable islet-containing encapsulation devices

1 reference

12 December 2020

Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases

1 reference

12 December 2020

Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice

1 reference

12 December 2020

The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction

1 reference

12 December 2020

Inorganic nanoporous membranes for immunoisolated cell-based drug delivery

1 reference

12 December 2020

The growth of cells in vivo in diffusion chambers. II. The role of cells in the destruction of homografts in mice

1 reference

12 December 2020

Recent developments in the transparent-chamber technique as adapted to the mouse

1 reference

12 December 2020

The diffusion-chamber technique applied to a study of the nature of homograft resistance

1 reference

12 December 2020

Development of a new method to induce angiogenesis at subcutaneous site of streptozotocin-induced diabetic rats for islet transplantation

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRD.2016.232

1 reference

Dimensions Publication ID

8 September 2017

1042884808

0 references

Fatcat ID

release_45bjsyqpgbax7jyibq5tifzivm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/45bjsyqpgbax7jyibq5tifzivm

24 November 2022

mapped directly with Wikidata item

1 reference